Table 3.
Clinical consequences of 87 patients with STEC-HUS
| Variables | n (%) |
|---|---|
| Anuria | 44 (51) |
| Oliguria | 25 (29) |
| Major CNS symptoms | 29 (33) |
| Seizures | 24 (28) |
| Impaired consciousness | 15 (17) |
| Hemiparesis | 4 (5) |
| Minor CNS symptoms | 12 (14) |
| Lethargy | 8 (9) |
| Irritability | 2 (2) |
| Vision abnormality | 1 (1) |
| Speech abnormality | 1 (1) |
| Fluctuating hemiparesis | 1 (1) |
| Hypertension | 30 (34) |
| Extrarenal manifestations | |
| Elevated transaminase level | 43 (49) |
| Pleural effusion | 17 (20) |
| Elevated amylase level | 13 (15) |
| Pericardial effusion | 6 (7) |
| Ascites | 5 (6) |
| Decreased myocardial function | 4 (5) |
| Pulmonary embolism | 1 (1) |
| Rhabdomyolysis | 1 (1) |
| Gallstones* | 1 (1) |
*Developed 1 month after the acute episode